SFLT-1/PLGF RATIO / SERUM

image not found

NABL Cap Accredited     
The sFlt-1/PlGF ratio test measures the balance between two important placental markers used to assess the risk of preeclampsia in pregnancy. Elevated sFlt-1 and reduced PlGF levels may indicate placental dysfunction, helping clinicians identify high-risk patients early. This ratio is valuable for predicting disease severity, guiding monitoring, and making timely clinical decisions. Metropolis Healthcare performs this serum-based test using advanced immunoassay technology to ensure precise and reliable assessment 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,150.00

Sample Type: SERUM

Fasting Not Required


Notes: S0549

Frequently Asked Questions (FAQ's):

What does the sFlt-1/PlGF ratio test measure?
It evaluates the balance between anti-angiogenic (sFlt-1) and pro-angiogenic (PlGF) markers linked to placental health.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-sensitivity immunoassays to accurately quantify sFlt-1 and PlGF levels and calculate the ratio.

Why is this test important in pregnancy?
It helps predict the risk and severity of preeclampsia, enabling timely medical intervention.

Who should take this test?
Pregnant women with high blood pressure, swelling, proteinuria, or suspected placental complications.

Do I need to fast before the test?
No fasting or special instructions are required.

What sample is needed?
A serum sample collected through a standard blood draw.

Can this test help in monitoring?
Yes, changes in the sFlt-1/PlGF ratio help monitor disease progression and guide obstetric management.

Does Metropolis Healthcare offer related pregnancy screening tests?
Yes, Metropolis Healthcare provides comprehensive maternal health and prenatal screening panels

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab